SS

Satpal Singh

Active Director Director DIN 10954958
DIN 10954958 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Satpal Singh

Data last updated:

Satpal Singh is a Director at Ryvosia Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 10954958
Primary Designation Director
Industry Paper
First Appointment 18 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20252025Active

Board colleagues of Satpal Singh

NameDINCompanyDesignation
Aaryan Singh08144589Ryvosia Pharmaceuticals Private LimitedIndividual Subscriber
Sanjay Kumar Yadav10954957Ryvosia Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Ryvosia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Satpal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satpal Singh

Satpal Singh currently holds 1 directorship: Ryvosia Pharmaceuticals Private Limited (Director, since 18 Feb 2025).

Satpal Singh was first appointed on 18 Feb 2025 as Director at Ryvosia Pharmaceuticals Private Limited.

The current boards of Satpal Singh's companies include Aaryan Singh (Ryvosia Pharmaceuticals Private Limited), Sanjay Kumar Yadav (Ryvosia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available